In fact, resistance mechanisms reduce the response rate,52 and the absence of antigen-specific T cells into the tumor microenvironment represents the biggest limitation

In fact, resistance mechanisms reduce the response rate,52 and the absence of antigen-specific T cells into the tumor microenvironment represents the biggest limitation. of the nanovaccine together with a checkpoint inhibitor increases the effectiveness of the Lazabemide treatment (87.5% of the animals responding, with 2 remissions) compared to the checkpoint Continue Reading